Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Oct 19;14(10):e244451.
doi: 10.1136/bcr-2021-244451.

Sjögren-related cardiomyopathy presenting with cardiogenic shock

Affiliations
Case Reports

Sjögren-related cardiomyopathy presenting with cardiogenic shock

Yahia Al Turk et al. BMJ Case Rep. .

Abstract

Previous reports have described non-ischaemic cardiomyopathy related to a variety of autoimmune diseases. However, very few case reports describe Sjögren disease as a contributing factor to cardiomyopathy. We report the case of a 69-year-old woman with a history of Sjögren disease who presented with cardiogenic shock. Laboratory testing and cardiac MRI revealing apical septal late gadolinium enhancement were consistent with an autoimmune aetiology. After ruling out ischaemic, infectious and other possible causes, the patient's clinical presentation was thought to be related to underlying Sjögren disease. She was treated with intravenous steroids and evidence-based heart failure therapy, but she eventually died after having declined heart transplantation. Given the rarity of Sjögren disease, no diagnostic criteria or standard treatment has been established for cardiomyopathy related to this disease. Diagnosis should be considered in patients who show evidence of autoimmune processes after other possible causes are ruled out.

Keywords: Sjogren's syndrome; cardiovascular medicine; heart failure; intensive care.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
ECG on presentation.
Figure 2
Figure 2
Transthoracic echocardiogram.
Figure 3
Figure 3
Late gadolinium enhancement cardiac MRI.

References

    1. Ramos-Casals M, Tzioufas AG, Font J. Primary Sjögren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 2005;64:347–54. 10.1136/ard.2004.025676 - DOI - PMC - PubMed
    1. Asmussen K, Andersen V, Bendixen G, et al. . A new model for classification of disease manifestations in primary sjögren's syndrome: evaluation in a retrospective long-term study. J Intern Med 1996;239:475–82. 10.1046/j.1365-2796.1996.418817000.x - DOI - PubMed
    1. Gyöngyösi M, Pokorny G, Jambrik Z, et al. . Cardiac manifestations in primary sjögren's syndrome. Ann Rheum Dis 1996;55:450–4. 10.1136/ard.55.7.450 - DOI - PMC - PubMed
    1. Barendregt PJ, Tulen JHM, van den Meiracker AH, et al. . Spectral analysis of heart rate and blood pressure variability in primary Sjögren's syndrome. Ann Rheum Dis 2002;61:232–6. 10.1136/ard.61.3.232 - DOI - PMC - PubMed
    1. Levin MD, Zoet-Nugteren SK, Markusse HM. Myocarditis and primary sjögren's syndrome. Lancet 1999;354:128–9. 10.1016/S0140-6736(99)02251-5 - DOI - PubMed

Publication types